Transurethral Cystolithotripsy vs Percutaneous Cystolithotomy for Bladder Stones in Children: A Systematic Review and

Xingming Zhao1,2, Qiang Guo1, Sheng Ren2

  • 1Department of Urology, The Second Hospital of Shanxi Medical University, Taiyuan, China.

PubMed

Insights

Transurethral cystolithotripsy (TUCL) and percutaneous cystolithotomy (PCCL) are safe for pediatric bladder stones (BS). PCCL offers shorter operative times, while TUCL has shorter hospital stays, with comparable effectiveness.

Area of Science:

  • Pediatric Urology
  • Minimally Invasive Surgery
  • Nephrolithiasis Treatment

Background:

  • Minimally invasive treatments for pediatric bladder stones (BS), including transurethral cystolithotripsy (TUCL) and percutaneous cystolithotomy (PCCL), are established as safe and effective.
  • Uncertainty persists regarding the comparative surgical outcomes and potential complications between TUCL and PCCL for pediatric BS.
  • A comprehensive understanding of long-term stone-free rates (SFR), postoperative complications, and cost-effectiveness is crucial for optimizing treatment selection.

Purpose of the Study:

  • To conduct a meta-analysis comparing transurethral cystolithotripsy (TUCL) and percutaneous cystolithotomy (PCCL) for the treatment of bladder stones (BS) in pediatric patients.
  • To evaluate and compare key outcomes including long-term stone-free rates (SFR), postoperative complications, operative time, hospital stay, and cost-effectiveness.
  • To provide evidence-based insights to guide the selection of the optimal surgical approach for pediatric bladder stones.

Main Methods:

  • A systematic meta-analysis was performed, searching PubMed, Embase, Cochrane Library, and Web of Science up to September 12, 2023.
  • Studies evaluating SFR, operation time, hospital stay, and complications in pediatric patients undergoing TUCL or PCCL for bladder stones were included.
  • Study quality was assessed using Cochrane tools and the Newcastle-Ottawa Scale system.

Main Results:

  • Seven studies encompassing 397 pediatric patients (202 TUCL, 195 PCCL) met the inclusion criteria.
  • Percutaneous cystolithotomy (PCCL) demonstrated significantly shorter operative times compared to transurethral cystolithotripsy (TUCL) (p < 0.00001).
  • Transurethral cystolithotripsy (TUCL) was associated with significantly shorter hospitalization days than PCCL (p < 0.00001); other perioperative outcomes showed no significant differences.

Conclusions:

  • Both transurethral cystolithotripsy (TUCL) and percutaneous cystolithotomy (PCCL) are effective and safe treatment options for pediatric bladder stones (BS).
  • The choice between TUCL and PCCL may depend on balancing operative time against hospital stay duration.
  • Further multicenter, large-patient series, and prospective studies are warranted to establish definitive guidelines, particularly regarding the critical stone size for surgical approach selection.